Adoption of a “Pathogenic, Predisposing, Risk and Benign” classification of DNA variants for precision medicine – a step forward
SMART-MD Journal of Precision Medicine · 2025
DOI: 10.69734/h7x6zm57 ↗Kurz gefasst
Fachartikel in der Zeitschrift SMART-MD Journal of Precision Medicine, 2025. Verfasst von David C. Whitcomb. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Precision medicine is often at odds with medical genetics in classifying gene mutations that have high impact on protein expression or function but do not “cause” disease. A new proposal aims to expand the terminology for genetic variants along a spectrum: (1) pathogenic (retaining Medical Genetics meaning) (2) predisposing (new term) (3) risk (as used in PRS) (4) benign (used in contrast to “pathogenic” but may be “predisposing” in some circumstances and context) This framework bridges the gap between binary classifications and the nuanced reality of variant effects, paving the way for more accurate risk assessment in clinical practice. It is time for adoption by geneticists and major professional societies.
Zitieren
APA
Whitcomb, D. C. (2025). Adoption of a “Pathogenic, Predisposing, Risk and Benign” classification of DNA variants for precision medicine – a step forward. SMART-MD Journal of Precision Medicine. https://doi.org/10.69734/h7x6zm57
Vancouver
Whitcomb DC. Adoption of a “Pathogenic, Predisposing, Risk and Benign” classification of DNA variants for precision medicine – a step forward. SMART-MD Journal of Precision Medicine. 2025. doi:10.69734/h7x6zm57
BibTeX
@article{Whitcomb2025,
author = {Whitcomb, David C.},
title = {Adoption of a “Pathogenic, Predisposing, Risk and Benign” classification of DNA variants for precision medicine – a step forward},
journal = {SMART-MD Journal of Precision Medicine},
year = {2025},
doi = {10.69734/h7x6zm57}
}
EUVIMED